MedTrace Logo

Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial

NCT03926390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-06-23

No results posted yet for this study

Summary

The aim was to assess the ability of bovine colostrum concentrate to reduce the incidence of late-onset sepsis episodes and necrotizing enterocolitis in artificially fed preterm neonates and its effect on T regulatory cells. And to evaluate the effect of bovine colostrum concentrate on feeding tolerance, growth, hospital stay and mortality in preterm neonates.

Conditions

  • Late Onset Neonatal Sepsis
  • Necrotizing Enterocolitis of Newborn
  • Feeding; Difficult, Newborn

Interventions

DIETARY_SUPPLEMENT

Bovine colostrum

bovine colostrum for first 2 weeks

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Hisham Awad · professor of pediatrics Ain Shams university

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
24 Hours
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2019-06-15
Completion
2019-09-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03926390 on ClinicalTrials.gov